Net loss per share (Details) - shares	12 Months Ended
Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Anti-dilutive securities
Anti-dilutive securities (in shares)	14,736,953	11,944,664	9,199,512
Stock options
Anti-dilutive securities
Anti-dilutive securities (in shares)	10,902,845	10,051,283	8,342,429
Unvested restricted stock units
Anti-dilutive securities
Anti-dilutive securities (in shares)	3,834,108	1,870,791	817,609
Warrants
Anti-dilutive securities
Anti-dilutive securities (in shares)	0	22,590	39,474

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration